Texas VA Hospital Buys Cepheid’s Xpert MRSA Kit | GenomeWeb
NEW YORK (GenomeWeb News) — A Veterans Affairs hospital in Houston has bought a Cepheid test that detects antibiotic-resistant staphylococcus bacteria, the company said today.
Cepheid said the Michael E. DeBakey VA Medical Center has bought its GeneXpert MRSA kit, which tests for methicillin-resistant staphylococcus, the most common cause of nosocomial infections.
The MRSA also is resistant to oxacillin, penicillin, and amoxicillin, and affects those with weakened immune systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.